Structure |
Chemical Name |
CAS |
MF |
 |
Medetomidine Impurity 14 |
79924-14-4 |
C13H16N2 |
 |
Tenofovir Disoproxil Impurity B |
36817-69-3 |
C8H11N5O |
 |
Ipragliflozin IMP |
|
|
 |
Oseltamivir Impurity 77 |
|
|
 |
Imidapril Impurity 2 |
|
|
 |
11α,17,21-トリヒドロキシ-16β-メチルプレグナ-1,4-ジエン-3,20-ジオン |
85700-75-0 |
C22H30O5 |
 |
Crisaborole Impurity ABCDEFGHJKL |
|
|
![3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]-](/CAS/20210305/GIF/2474774-17-7.gif) |
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |
![2,3'-Bipyridine, 5-chloro-3-[4-(methylsulfonyl)phenyl]-, hydrochloride (1:1)](/CAS/20210111/GIF/202409-39-0.gif) |
2,3'-Bipyridine, 5-chloro-3-[4-(methylsulfonyl)phenyl]-, hydrochloride (1:1) |
202409-39-0 |
C17H14Cl2N2O2S |
 |
1,1'-((methylenebis(4-methoxy-3,1-phenylene))bis(2-(dimethylamino)ethane-1,1-diyl))dicyclohexanol |
|
|
 |
2-amino-4-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)phenol |
|
|
 |
Peramivir Deacetyl Impurity |
|
|
 |
Empagliflozin Impurity 116 |
|
|
![(3R,5aS)-5,8-dioxooctahydro-5H-pyrrolo[1,2-a]thiazolo[3,2-d]pyrazine-3-carboxylic acid](/) |
(3R,5aS)-5,8-dioxooctahydro-5H-pyrrolo[1,2-a]thiazolo[3,2-d]pyrazine-3-carboxylic acid |
|
|
 |
Phospholipid Impurity 1(DPPE-MPEG5000 Impurity 1) |
|
|
 |
Carbazochrome Sodium Sulfonate Impurity 4 |
|
|
 |
Empagliflozin Furanose Impurity |
|
|
 |
Rosuvastatin Impurity 144 |
|
|
 |
Cetrorelix Impurity 11 |
|
|
 |
Cetrorelix Impurity 4 (8-D-Arg) |
|
|
 |
Cetrorelix Impurity 1 (+L-Arg) |
|
|
 |
Peramivir Intermediate Impurity 36 |
|
|
 |
Peramivir Intermediate Impurity 41 |
|
|
 |
Peramivir Impurity 999 |
|
|
 |
Palonosetron impurity 20XH |
|
|
 |
Levofloxacin benzopazine impurity |
|
|
 |
Bumetanide Impurity 14 |
1431501-10-8 |
C21H27NO3 |
![Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride](/) |
Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride |
|
|
 |
Sugammadex Sodium Impurity 08 |
|
|
![2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/) |
2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2412953-12-7 |
C72H112O49S8 |
 |
4a(2H)-Isoquinolinol, octahydro-4-(4-methoxyphenyl)-2-methyl- |
2568340-30-5 |
C17H25NO2 |
![3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-](/CAS/20210305/GIF/2468737-92-8.gif) |
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-92-8 |
C25H27Cl2N5O3 |
 |
Uridine, 4-oxime, 5'-(2-methylpropanoate), (4E)- |
2492423-30-8 |
C13H19N3O7 |
 |
Empagliflozin Furanose Impurity |
|
|
 |
Tazobactam Impurity XTE |
|
|
 |
Isavuconazole Impurity 46 |
|
|
 |
5-(1-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-2-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
2226428-25-5 |
C24H28N2O3 |
 |
INDEX NAME NOT YET ASSIGNED |
2740235-22-5 |
C13H22N2O5 |
![2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/CAS/20181212/GIF/CB810019553.gif) |
2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
|
C23H30FN3 |
 |
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-rel- |
2184053-08-3 |
C17H17Cl2N |
 |
Rosuvastatin Impurity 152 |
|
|
 |
1-(4-(2-(アゼパン-1-イル)エトキシ)ベンジル)-5-(ベンジルオキシ)-2-(4-(ベンジルオキシ)フェニル)-3-メチル-1H-インドール |
198480-21-6 |
C44H46N2O3 |
![6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5R,6E)-](/CAS/20210305/GIF/2273873-66-6.gif) |
6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5R,6E)- |
2273873-66-6 |
C29H32FNO4 |
 |
2H-1,4-Benzoxazin-3(4H)-one, 8-(2-chloro-1-hydroxyethyl)-6-(phenylmethoxy)- |
2383660-53-3 |
C17H16ClNO4 |
 |
Isavuconazole Impurity 40 |
|
|
 |
(2R,3S,4R,5R,6S)-2-((R)-1,2-dihydroxyethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
![2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide](/CAS/20210305/GIF/2724840-93-9.gif) |
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide |
2724840-93-9 |
C18H15ClN2O4S |
 |
Vitamin K1 Impurity C |
|
|
![4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide](/) |
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide |
|
|
 |
1-(4-Bromo-2-(hydroxymethyl)phenyl)-4-(dimethylamino)-1-(4-fluorophenyl)butan-1-olhydrochloride |
488148-10-3 |
C19H23BrFNO2 |
 |
Bisoprolol Impurity 42 |
|
|
 |
Peramivir Impurity 31(R) |
|
|
 |
Roxatidine Impurity 10 |
|
|
 |
Pitavastatin 5-Oxo Impurity Calcium Salt |
2180095-22-9 |
C25H24CaFNO4 |
 |
1-(2-bromo-3,5-dihydroxyphenyl)ethanone |
2092614-65-6 |
C8H7BrO3 |
 |
Lenvatinib impurity LFZZ-18 |
|
C11H8Cl2N2O2 |
 |
Rosuvastatin Impurity 121 |
140164-51-8 |
C10H18O5 |
 |
Brivaracetam Impurity 38 |
|
|
 |
Isavuconazole Impurities 04 |
|
|
 |
Ticagrelor Impurity 119 |
|
|
 |
Ticagrelor Impurity 118 |
|
|
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) |
402508-35-4 |
C11H18O6 |
![L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]-](/CAS/20200611/GIF/112246-66-9.gif) |
L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]- |
112246-66-9 |
C5H9NO5S |
![2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]-](/CAS/20200611/GIF/1902955-67-2.gif) |
2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]- |
1902955-67-2 |
C17H20N4OS |
![3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl-](/CAS/20200611/GIF/52240-42-3.gif) |
3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl- |
52240-42-3 |
C13H17N3O |
![Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]-](/CAS/20200611/GIF/938143-02-3.gif) |
Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- |
938143-02-3 |
C14H18N2O3 |
 |
1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
|
|
 |
2,4-bis(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole |
|
|
 |
2-((4R,6S)-6-((2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetoxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
|
|
 |
1,3-bis(4-((E)-3-methoxy-3-oxoprop-1-en-1-yl)benzyl)-1H-imidazol-3-ium bromide |
|
|
 |
Crisaborole intermediate |
1187230-70-1 |
C14H14BNO3 |
![Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)-](/CAS/20210111/GIF/1449784-97-7.gif) |
Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)- |
1449784-97-7 |
C23H29N5O8S |
![6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy-](/CAS/20210111/GIF/2380197-89-5.gif) |
6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy- |
2380197-89-5 |
C17H14ClN3O3 |
 |
1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, methyl ester, (4R)- |
930123-52-7 |
C12H21NO3 |
 |
Traxipide impurity |
|
|
![Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester](/CAS/20210305/GIF/1181267-38-8.gif) |
Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester |
1181267-38-8 |
C29H39N3O3 |
![Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]-](/CAS/20210111/GIF/1039828-27-7.gif) |
Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]- |
1039828-27-7 |
C12H18O3 |
 |
Brivaracetam Impurity 7 HCl |
357338-46-6 |
C13H27ClN2O3 |
 |
Bisacodyl Impurity 1 |
13004-51-8 |
C18H15NO2 |
 |
Vecuronium Bromide ImpurityACDEFGHJKL |
|
|
![Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)-](/CAS/20210111/GIF/1640981-02-7.gif) |
Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)- |
1640981-02-7 |
C18H20N2O4 |
 |
INDEX NAME NOT YET ASSIGNED |
2452300-94-4 |
C21H25ClO8 |
![1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-](/CAS/20200611/GIF/1576240-15-7.gif) |
1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-15-7 |
C24H28FN3O |
 |
1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)- |
357334-83-9 |
C11H20N2O2 |
 |
impurity 42 |
|
|
 |
3-(hydroxy(2-methyl-1H-imidazol-1-yl)methyl)-9-(hydroxymethyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
|
 |
Perospirone Impurity 18 |
|
|
 |
Perospirone Impurity 3 |
1002359-81-0 |
C8H11NO2 |
 |
Dolutegravir Impurity 13(Sodium Salt) |
|
|
 |
Paxlovid Impurity 10 |
|
|
 |
Fondaparinux sodium impurity 4 |
|
|
 |
Ampicillin Impurity W |
|
|
 |
Lasmiditan Impurity 5 |
|
|
 |
Olodaterol Impurity 18 |
2727170-18-3 |
|
 |
Febuxostat impurity DAC |
|
|
 |
1-メチル-2-オキソシクロペンタンカルボン酸エチル |
5453-88-3 |
C9H14O3 |
 |
Olodaterol Impurity 27 |
|
|
 |
Ethacridine Impurity 9 |
|
|
 |
isopropyl 2-(2-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate |
|
|